Executive Summary
On June 23, 2026, Beijing unveiled a 15-point action plan designed to reverse the slide in foreign direct investment (FDI) into China. The plan — issued jointly by multiple central government bodies — targets two fronts simultaneously: expanding the sectors where foreign capital is welcome, and stripping away the operational friction that makes “welcome” feel theoretical. This is not a standalone gesture. It arrives alongside a cluster of complementary policy moves: a new cross-border data negative list in Tianjin, expanded tax benefits in Shenzhen’s Qianhai zone, science-and-technology investment facilitation rules from MOFCOM, and Beijing’s decision to lift property investment curbs for foreign firms. Together, they constitute the most concentrated foreign-investment policy push since the 2024 State Council circular on stabilizing foreign capital.
The number to remember: FDI into China fell 8.6% year-on-year by value in the first five months of 2026. That is the context. The 15-point plan is the response. This article unpacks what is actually in it — and what foreign businesses should do now.
Context: The FDI Slide That Forced Action
China’s foreign direct investment figures have been softening for several years, but 2026’s trajectory sharpened the urgency. Ministry of Commerce (MOFCOM, 商务部) data shows that while the number of newly established foreign-invested enterprises rose 5.3% in January-May 2026 — a sign that market interest persists — the value of actual utilized foreign capital fell 8.6% over the same period. New companies are being registered, but they are smaller. Capital inflows are thinning.
Three forces are compressing FDI simultaneously. First, geopolitical decoupling pressure continues to push multinational supply chains toward diversification — Vietnam, India, Mexico — even when China remains cost-competitive. Second, domestic regulatory complexity still deters mid-market foreign firms that lack the legal and compliance infrastructure of a Fortune 500 multinational. Third, a slowing Chinese economy means the domestic market opportunity, while still enormous, no longer guarantees the double-digit growth rates that justified regulatory headaches a decade ago.
The 15-point plan is not China’s first attempt to arrest this trend. The 2024 State Council “Opinions on Further Optimizing the Foreign Investment Environment and Increasing Efforts to Attract Foreign Investment” set broad policy direction. The 2025 Negative List for foreign investment access (外商投资准入负面清单, wàishāng tóuzī zhǔnrù fùmiàn qīngdān) cut restricted items from 33 to 29. But FDI continued to decline. This latest plan signals a shift from general statements of intent to operational specifics — and it comes with teeth in the form of implementation timelines and ministerial accountability.
Deep Analysis — Four Dimensions of the 15-Point Plan
Dimension 1: Market Access — Which Doors Are Opening Wider
The plan’s market access provisions target sectors where foreign participation has been technically permitted but practically constrained. Healthcare services, value-added telecommunications, and certain segments of cultural and entertainment services receive explicit mention — sectors where the 2025 Negative List already allowed foreign investment but where sub-national licensing and opaque approval processes created de facto barriers.
For healthcare, the plan commits to streamlining the approval process for wholly foreign-owned hospitals in designated cities. This builds on a 2024 pilot that permitted foreign-owned hospitals in nine cities including Beijing, Shanghai, and Guangzhou, but which saw only a handful of applications succeed. The new language adds binding processing timelines: 45 working days for provincial-level health authority review, down from the previous open-ended window. For medical device and pharmaceutical firms, the plan promises “national treatment” in government procurement — meaning foreign-made products that meet Chinese standards should not face the informal preference for domestic suppliers that currently pervades provincial tender processes.
In value-added telecommunications, the plan extends the geographical scope of foreign ownership pilots beyond the existing five Free Trade Zones. E-commerce, data center operations, and cloud services — currently capped at 50% foreign ownership in most locations — will see pilot zones where 100% foreign ownership is permitted, subject to cybersecurity review. This matters enormously for foreign tech firms that have been locked out of China’s cloud infrastructure market, which reached RMB 480 billion (approximately USD 66 billion) in 2025.
The data point: Value-added telecom services generated RMB 2.1 trillion in revenue in 2025. Foreign firms currently capture less than 3% of that market. Even a modest liberalization shifts the addressable opportunity by tens of billions of dollars.
Dimension 2: Operational Barriers — What “Ease of Doing Business” Actually Means
The second dimension targets the day-to-day friction that foreign executives cite as the real deterrent — not the headline policies, but the cumulative weight of administrative requirements that slow everything from hiring to invoicing.
The plan introduces a “single-window” mechanism for foreign investment project filing, consolidating what currently requires separate submissions to MOFCOM, the National Development and Reform Commission (NDRC, 国家发展改革委), the State Administration for Market Regulation (SAMR, 国家市场监督管理总局), and — depending on the industry — sector-specific regulators. For a manufacturing WFOE (Wholly Foreign-Owned Enterprise), this could reduce the registration timeline from the current 45-60 days to a target of 30 days. The single-window concept is not new — it was piloted in Shanghai’s Lingang Special Area in 2025 — but the plan now mandates national rollout by Q4 2026.
Foreign exchange controls receive attention too. The plan commits to expanding the “convenient receipt and payment” pilot program for capital account transactions, currently available in the Lingang and Hainan Free Trade Port, to all 21 Free Trade Zones by year-end. Under this program, foreign-invested enterprises can process capital injections, profit repatriation, and cross-border loans without pre-approval from the State Administration of Foreign Exchange (SAFE, 国家外汇管理局) for transactions under USD 5 million. Above that threshold, documentation requirements are reduced from seven documents to three. For a mid-sized foreign manufacturer repatriating quarterly profits, this removes roughly 12-15 business days of processing time per transaction.
On the talent side, the plan extends the validity period for foreign expert work permits (外国专家工作许可, wàiguó zhuānjiā gōngzuò xǔkě) from one year to three years for positions in encouraged industries, and removes the requirement for degree authentication via Chinese consulates for applicants from 38 designated countries including the US, UK, Germany, Japan, and South Korea. This alone addresses one of the most persistent HR complaints from foreign firms: the three-to-four-month delay in getting a senior engineer or country manager physically on the ground.
Dimension 3: The Regional Pilot Layer — FTZs Are Becoming the Default, Not the Exception
The 15-point plan does not exist in isolation. It interlocks with a cascade of regional policy experiments that, taken together, are changing where and how foreign firms can operate in China. This is the third dimension: the geographic strategy.
In late June 2026, three regional moves converged with the national plan. Shenzhen’s Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone (前海深港现代服务业合作区) expanded its preferential corporate income tax (CIT) rate of 15% — versus the national 25% — to cover foreign-invested enterprises in six new service categories, including cross-border legal services, international arbitration, and maritime insurance. The individual income tax (IIT) subsidy for foreign talent was also extended, capping effective IIT at 15% for qualifying professionals, with the Qianhai government covering the difference between the standard progressive rate and the 15% cap. We covered this in detail in our Qianhai Zone tax benefits analysis.
Simultaneously, the Shanghai Lingang Special Area released its first “general data lists” — effectively a whitelist of data categories that foreign-invested enterprises can export without undergoing the full security assessment required under China’s cross-border data transfer regime. For a foreign manufacturer running a global ERP system with a node in Shanghai, this determines whether operational data can flow to headquarters in real time or must be held entirely onshore. The Lingang lists cover 11 industry sectors including automotive, biopharmaceuticals, and high-end equipment manufacturing. This follows the Tianjin Free Trade Zone’s release of China’s first negative list for cross-border data transfer, which established the template for location-specific data governance.
Beijing entered the regional race by lifting restrictions on foreign firms purchasing commercial property — a long-standing anomaly that treated foreign entities differently from domestic ones in real estate transactions. The change allows foreign-invested enterprises to acquire office space, R&D facilities, and commercial property without the previously required “commercial presence for three years” precondition.
The pattern: China is using its Free Trade Zones and special economic areas as laboratories. Policies proven in Lingang, Qianhai, and Hainan are being elevated to national policy faster than at any point in the last decade. For foreign firms, this means the location decision now carries policy weight: incorporating in Qianhai versus downtown Shenzhen, or in Lingang versus downtown Shanghai, can mean a 10-percentage-point difference in effective tax rate and a dramatically different data compliance burden.
Dimension 4: Technology and Data — The Balancing Act
The fourth dimension is the most delicate. China wants foreign technology investment — the 15-point plan explicitly encourages foreign participation in R&D centers, innovation platforms, and technology transfer — but it simultaneously maintains one of the world’s most restrictive cross-border data regimes. The tension between these two objectives defines the technology provisions of the plan.
The plan introduces a “trusted foreign investor” designation for R&D-intensive enterprises. Qualifying firms — those with at least RMB 50 million in accumulated R&D investment in China and a clean regulatory record over three years — receive expedited data export security reviews with a target turnaround of 30 working days, down from the standard 60-plus. They also gain eligibility for national R&D subsidy programs that were previously restricted to domestic enterprises. A foreign pharmaceutical company running clinical trials in China, for example, could now apply for government co-funding of Phase III trials under the same terms as a Chinese biotech firm. This aligns with the MOFCOM sci-tech facilitation rules we analyzed in June.
However, the plan also reinforces China’s technology sovereignty framework. Foreign enterprises seeking to participate in government-funded R&D programs must establish a “data management entity” within China — a local legal structure responsible for compliance with the Data Security Law (数据安全法, shùjù ānquán fǎ) and Personal Information Protection Law (个人信息保护法, gèrén xìnxī bǎohù fǎ). The entity must be staffed by personnel with Chinese cybersecurity certifications and must maintain all R&D data on servers physically located in mainland China. For foreign firms, this means an additional layer of compliance infrastructure — estimated at RMB 2-5 million annually for a mid-sized R&D operation — but also a path to accessing government R&D funds that were previously out of reach.
The Tianjin Free Trade Zone’s parallel release of China’s first “negative list for cross-border data transfer” provides the operational template. Instead of requiring pre-approval for all data exports, the Tianjin model specifies categories of data that cannot be exported — and, by implication, treats everything else as permissible under standard compliance procedures. If this model scales nationally, it would represent the most significant liberalization of China’s data export regime since the Cybersecurity Law took effect in 2017.
Impact Assessment: Who Gains, Who Should Wait
Not all foreign businesses benefit equally from the 15-point plan. The impact divides along industry lines, investment stage, and location strategy.
Immediate beneficiaries include foreign pharmaceutical and medical device companies — the combination of national treatment in procurement, expedited clinical trial approvals, and R&D subsidy eligibility creates a materially improved operating environment. Foreign firms in advanced manufacturing, particularly those with existing R&D centers in China, gain from the trusted investor designation and the Lingang data export whitelists. Professional service firms — legal, consulting, arbitration — benefit from the Qianhai CIT expansion and the broader signal that service-sector liberalization is real.
Conditional beneficiaries include foreign technology companies in cloud services and data centers, where the pilot expansions are real but geographically limited. A cloud provider can now establish a 100% foreign-owned data center in a designated pilot zone, but serving clients nationwide still requires partnering with a domestic telecom carrier — and the cybersecurity review process remains politically sensitive. Consumer-facing internet platforms and social media companies see minimal benefit; the plan does not address the content regulation and licensing framework that governs their sector.
Wait-and-see cases include financial services firms, where the plan defers to separate opening schedules managed by the National Financial Regulatory Administration (NFRA, 国家金融监督管理总局). Foreign banks and insurers seeking expanded licenses will find nothing new here — their liberalization track runs on a separate, slower timetable.
Actionable Recommendations
For foreign businesses evaluating or operating in China, the 15-point plan creates a window for specific, time-bound actions:
- Reassess your corporate structure. If your China entity was established before 2024, it likely predates the current wave of FTZ incentives. Incorporating a subsidiary in Lingang, Qianhai, or Hainan — even if your existing WFOE remains operational — can unlock the 15% CIT rate and data export facilitation. The cost of a second entity (typically RMB 50,000-100,000 in registration fees plus annual compliance) should be weighed against the tax and operational savings over a three-year horizon.
- Apply for trusted foreign investor status. If your China R&D spend exceeds RMB 50 million cumulatively, begin preparing the application now. The documentation requirements — three years of regulatory compliance records, audited R&D expenditure, data management entity registration — will take 8-12 weeks to assemble. Early applicants will benefit from the expedited review lane before the pipeline fills.
- Audit your data architecture. The Lingang general data lists and the Tianjin negative list together signal that China’s data export regime is fragmenting by location. Data that requires a security assessment if exported from Beijing may flow freely from Lingang. Map your data flows — what originates where, what crosses borders, what falls into which regulatory category — and align your server architecture with the most permissive jurisdiction available.
- Engage on government procurement. The national treatment commitment in procurement is only as good as its enforcement at the provincial level. For foreign medical device and pharmaceutical firms, now is the moment to submit provincial tender applications that you may have previously bypassed based on informal advice that foreign firms would not be competitive. Document any rejection that appears inconsistent with the national treatment commitment — these patterns will inform MOFCOM’s enforcement mechanism.
- Monitor the timeline. The single-window filing mechanism is scheduled for national rollout by Q4 2026. If your planned China investment can be timed for late Q4 or Q1 2027, you will benefit from the streamlined process. If you must file before then, expect the current multi-agency timeline and budget accordingly.
The number to leave with: A foreign manufacturer establishing a WFOE in Lingang today, with trusted investor status and utilizing the capital account facilitation program, can expect to be operational in 30 days with a 15% effective CIT rate and streamlined data export — compared to 60 days, 25% CIT, and full security assessment requirements for an identical investment two years ago. The gap between available policy and utilized policy is where competitive advantage lives. Most of your competitors are not tracking these changes. That is your window.
— China Gateway 360 —
Remote China market entry support, built around execution.